Literature DB >> 9761490

The renal risks of high-dose intravenous immunoglobulin treatment.

M Stahl, J A Schifferli.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9761490     DOI： 10.1093/ndt/13.9.2182

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Increased risk of adverse events when changing intravenous immunoglobulin preparations.

Authors:  R Ameratunga; J Sinclair; J Kolbe
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 2.  [Intravenous immunoglobulins in chronic idiopathic myositis].

Authors:  H Michels; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.